This increase was recorded through our RNG segment royalty expense. For the 6 months of 2024, we incurred approximately $40,800,000 in capital expenditures, of which $19,000,000 related to our Montauk Ag Renewables development in North Carolina, dollars 6,900,000 to the 2nd Apex facility, dollars 6,700,000 to our Bowerman RNG project, dollars 1,800,000 to the Blue Granite RNG project and $1,300,000 for our PECO digestion capacity increase. As of June 30, 2024, we had cash and cash equivalents of approximately $42,300,000 and accounts and other receivables of approximately $22,000,000 dollars Accounts receivable primarily relate to 2nd quarter RIN sales comprising the majority of this balance, of which the majority was collected after June 30, 2024. Adjusted EBITDA for the Q2 of 2024 was $7,000,000 a decrease of $12,200,000 compared to $19,200,000 for the Q2 of 2023. EBITDA for the Q2 of 2024 was 6,700,000 dollars a decrease of $12,200,000 or 64.3 percent compared to EBITDA of $18,900,000 for the Q2 of 2023.